Astex Pharmaceuticals, Inc.

The pharmaceutical, biotech and other allied industries came together in London on 4 December to celebrate another year of exceptional achievement at the 20th Annual Scrip Awards at the Raffles hotel

The US Food and Drug Administration beats the European Medicines Agency to approval of novel agents across the board, but the imbalance is even more stark in oncology, the largest therapy area, a Pin

In 2023, the European Commission approved 36 medicines containing a new active substance, the lowest number since 2019 when just 28 NAS-containing drugs gained an EU-wide marketing authorization. Amon

Astex Pharmaceuticals, Inc. has clinched its third oncology partnership with MSD with a focus on the notoriously difficult p53 transcription factor target for $35m upfront after two prior deals suc